Ammira S. Akil-Shabeeb

Doha, DA, Qatar

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Synthetic immunomodulators: Revolutionizing immunotherapy.

Synthetic immunomodulators: Revolutionizing immunotherapy.

Journal: Advances in protein chemistry and structural biology

Published: May 14, 2026

Regulated cell death plasticity in cancer: thresholds, reversibility, and therapeutic failure.

Regulated cell death plasticity in cancer: thresholds, reversibility, and therapeutic failure.

Journal: Journal of translational medicine

Published: March 22, 2026

Metronomic Chemotherapy in Ovarian Cancer: Current Scenario and AI-Integrated Future Strategies.

Metronomic Chemotherapy in Ovarian Cancer: Current Scenario and AI-Integrated Future Strategies.

Journal: Cancer reports (Hoboken, N.J.)

Published: December 24, 2025

p53 Aggregation in cancer: Molecular mechanisms, functional disruptions, and targeted therapies.

p53 Aggregation in cancer: Molecular mechanisms, functional disruptions, and targeted therapies.

Journal: Advances in protein chemistry and structural biology

Published: November 27, 2025

Targeting ubiquitin-specific protease 14 reduces metastatic potential and metabolic activity in cervical cancer via direct modulation of monocarboxylate transporter-4.

Targeting ubiquitin-specific protease 14 reduces metastatic potential and metabolic activity in cervical cancer via direct modulation of monocarboxylate transporter-4.

Journal: Journal of translational medicine

Published: September 20, 2025

Ritscher-Schinzel syndrome can be characterized as an endosomal recyclinopathy.

Ritscher-Schinzel syndrome can be characterized as an endosomal recyclinopathy.

Journal: Science translational medicine

Published: July 02, 2025

Circular RNA profiling identifies circ_0001522, circ_0001278, and circ_0001801 as predictors of unfavorable prognosis and drivers of triple-negative breast cancer hallmarks.

Circular RNA profiling identifies circ_0001522, circ_0001278, and circ_0001801 as predictors of unfavorable prognosis and drivers of triple-negative breast cancer hallmarks.

Journal: Cell death discovery

Published: February 25, 2025

Role of lamins in cellular physiology and cancer.

Role of lamins in cellular physiology and cancer.

Journal: Advances in protein chemistry and structural biology

Published: January 22, 2025

Human papilloma virus infection drives unique metabolic and immune profiles in head and neck and cervical cancers: implications for targeted therapies and prognostic markers.

Human papilloma virus infection drives unique metabolic and immune profiles in head and neck and cervical cancers: implications for targeted therapies and prognostic markers.

Journal: Discover oncology

Published: December 31, 2024

Integrating network analysis with differential expression to uncover therapeutic and prognostic biomarkers in esophageal squamous cell carcinoma.

Integrating network analysis with differential expression to uncover therapeutic and prognostic biomarkers in esophageal squamous cell carcinoma.

Journal: Frontiers in molecular biosciences

Published: April 29, 2024

Therapeutic implications of signaling pathways and tumor microenvironment interactions in esophageal cancer.

Therapeutic implications of signaling pathways and tumor microenvironment interactions in esophageal cancer.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: March 24, 2024

Bortezomib exerts its anti-cancer activity through the regulation of Skp2/p53 axis in non-melanoma skin cancer cells and C. elegans.

Bortezomib exerts its anti-cancer activity through the regulation of Skp2/p53 axis in non-melanoma skin cancer cells and C. elegans.

Journal: Cell death discovery

Published: December 04, 2023

Showing 1-12 of 19

Last Updated: 09/26/2026